Divis Laboratories Ltd | DIVI - Gross Profit On Sales


Divis Laboratories Ltd reported INR19.61B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Aurobindo Pharma INR 54.79B 1.56B Jun/2026
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Lupin INR 55.4B 5.64B Mar/2026
Moderna USD -566M 792M Mar/2026
Organon & Co USD 847M 64M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
Tectonic Therapeutic USD 0 0 Mar/2025
Tilray USD 57.47M 10.16M Jun/2025
Viatris USD 1.57B 193.9M Jun/2026
Xeris Pharmaceuticals USD 72.55M 404K Mar/2026